STOCK TITAN

[Form 4] KORU Medical Systems, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Novanta Inc. (NASDAQ: NOVT) entered into a Fourth Amended & Restated Credit Agreement on 27 June 2025 that replaces its 2019 facility scheduled to mature in March 2027. The new agreement provides an aggregate senior secured credit capacity of approximately US$1.0 billion, broken down into:

  • €65.31 million 5-year Euro-denominated term loan
  • $75 million 5-year US-dollar term loan
  • $850 million 5-year revolving credit facility

The maturity is extended to June 2030, and an uncommitted accordion feature can raise total commitments by an additional $350 million, subject to customary conditions. Interest is set at (i) Base Rate + 0–0.75 ppt or (ii) SOFR/SONIA/EURIBOR + 1.00–1.75 ppt, with pricing tied to the company’s consolidated leverage ratio. A commitment fee applies to unused revolver capacity.

Key financial covenants tested quarterly include: (1) maximum consolidated leverage ratio of 3.5× (step-up to 4.0× for four quarters following qualifying acquisitions >= $50 million) and (2) minimum fixed-charge coverage ratio of 1.25×. The facilities are secured by senior liens on substantially all assets of Novanta and certain subsidiaries and contain customary negative covenants on mergers, asset sales, indebtedness, investments and liens.

Required quarterly principal amortization begins September 2025 for the Euro term loan and September 2026 for the US term loan, with final balloon payments due at maturity. Prepayments from asset sales, casualty events or incremental debt are mandatory, while voluntary prepayments and commitment reductions are permitted without premium.

Outstanding borrowings under the prior facility were $392.4 million as of 28 March 2025. The new structure enhances liquidity headroom, extends tenor, and provides interest-rate optionality, but also secures the debt and maintains leverage limits that investors should monitor.

Novanta Inc. (NASDAQ: NOVT) ha stipulato un Quarto Accordo di Credito Modificato e Rifirmato il 27 giugno 2025, che sostituisce la sua linea di credito del 2019 prevista in scadenza a marzo 2027. Il nuovo accordo prevede una capacità di credito senior garantito complessiva di circa 1,0 miliardi di dollari USA, suddivisa in:

  • 65,31 milioni di euro, prestito a termine quinquennale denominato in euro
  • 75 milioni di dollari, prestito a termine quinquennale denominato in dollari USA
  • 850 milioni di dollari, linea di credito revolving quinquennale

La scadenza è stata estesa a giugno 2030 e una clausola di estensione non vincolante può aumentare gli impegni totali di ulteriori 350 milioni di dollari, soggetti a condizioni consuete. Il tasso d’interesse è fissato a (i) Base Rate + 0–0,75 punti percentuali oppure (ii) SOFR/SONIA/EURIBOR + 1,00–1,75 punti percentuali, con il prezzo legato al rapporto di leva finanziaria consolidato della società. È prevista una commissione di impegno sulla capacità inutilizzata della linea revolving.

I principali covenant finanziari, verificati trimestralmente, includono: (1) un rapporto massimo di leva finanziaria consolidata di 3,5× (con aumento a 4,0× per quattro trimestri dopo acquisizioni qualificate ≥ 50 milioni di dollari) e (2) un rapporto minimo di copertura delle spese fisse di 1,25×. Le linee di credito sono garantite da privilegi senior su quasi tutti gli asset di Novanta e di alcune sue controllate e includono clausole negative standard riguardanti fusioni, vendite di asset, indebitamento, investimenti e privilegi.

L’ammortamento del capitale richiesto trimestralmente inizia a settembre 2025 per il prestito a termine in euro e a settembre 2026 per quello in dollari, con pagamenti finali a scadenza. I rimborsi anticipati derivanti da vendite di asset, eventi di danno o debito incrementale sono obbligatori, mentre quelli volontari e le riduzioni di impegno sono consentiti senza penali.

Le esposizioni in essere sotto la precedente linea erano di 392,4 milioni di dollari al 28 marzo 2025. La nuova struttura migliora la liquidità disponibile, estende la durata e offre opzioni sui tassi di interesse, ma garantisce anche il debito e mantiene limiti di leva finanziaria che gli investitori devono monitorare.

Novanta Inc. (NASDAQ: NOVT) firmó un Cuarto Acuerdo de Crédito Modificado y Restablecido el 27 de junio de 2025, que reemplaza su línea de crédito de 2019 programada para vencer en marzo de 2027. El nuevo acuerdo ofrece una capacidad de crédito senior garantizado total de aproximadamente 1.000 millones de dólares estadounidenses, desglosada en:

  • 65,31 millones de euros, préstamo a plazo a 5 años denominado en euros
  • 75 millones de dólares, préstamo a plazo a 5 años en dólares estadounidenses
  • 850 millones de dólares, línea de crédito revolvente a 5 años

La vencimiento se extiende hasta junio de 2030, y una característica de extensión no comprometida puede aumentar los compromisos totales en otros 350 millones de dólares, sujeto a condiciones habituales. El interés se establece en (i) Tasa Base + 0–0,75 puntos porcentuales o (ii) SOFR/SONIA/EURIBOR + 1,00–1,75 puntos porcentuales, con la tarifa ligada al ratio de apalancamiento consolidado de la empresa. Se aplica una comisión por compromiso sobre la capacidad no utilizada del revolvente.

Los principales covenants financieros evaluados trimestralmente incluyen: (1) ratio máximo de apalancamiento consolidado de 3,5× (aumento a 4,0× durante cuatro trimestres tras adquisiciones calificadas ≥ 50 millones de dólares) y (2) ratio mínimo de cobertura de gastos fijos de 1,25×. Las facilidades están garantizadas por gravámenes senior sobre prácticamente todos los activos de Novanta y ciertas subsidiarias, e incluyen cláusulas negativas habituales sobre fusiones, ventas de activos, endeudamiento, inversiones y gravámenes.

La amortización principal requerida trimestralmente comienza en septiembre de 2025 para el préstamo a plazo en euros y en septiembre de 2026 para el préstamo en dólares, con pagos finales al vencimiento. Los prepagos derivados de ventas de activos, eventos de siniestro o deuda incremental son obligatorios, mientras que los prepagos voluntarios y las reducciones de compromiso están permitidos sin penalización.

Los préstamos pendientes bajo la línea anterior eran de 392,4 millones de dólares al 28 de marzo de 2025. La nueva estructura mejora la liquidez disponible, extiende el plazo y ofrece opciones sobre tasas de interés, pero también garantiza la deuda y mantiene límites de apalancamiento que los inversores deben vigilar.

Novanta Inc. (NASDAQ: NOVT)는 2025년 6월 27일에 2019년 시설을 대체하는 4차 수정 및 재작성 신용 계약을 체결했습니다. 기존 시설은 2027년 3월 만기가 예정되어 있었습니다. 새 계약은 총 약 10억 달러의 선순위 담보 신용 한도를 제공하며, 세부 내역은 다음과 같습니다:

  • 6,531만 유로 5년 만기 유로화 대출
  • 7,500만 달러 5년 만기 미화 대출
  • 8억 5천만 달러 5년 만기 리볼빙 신용 한도

만기는 2030년 6월까지 연장되었으며, 비확약 확장 옵션을 통해 총 약정액을 추가로 3억 5천만 달러까지 늘릴 수 있습니다(통상 조건 충족 시). 이자는 (i) 기준금리 + 0~0.75%포인트 또는 (ii) SOFR/SONIA/EURIBOR + 1.00~1.75%포인트로 설정되며, 회사의 통합 레버리지 비율에 따라 금리가 조정됩니다. 미사용 리볼빙 한도에 대해 약정 수수료가 부과됩니다.

주요 재무 약정은 분기별로 검토되며, (1) 최대 통합 레버리지 비율 3.5배(50백만 달러 이상 적격 인수 후 4분기 동안 4.0배로 상향 조정) 및 (2) 최소 고정비용 커버리지 비율 1.25배를 포함합니다. 이 시설들은 Novanta 및 일부 자회사의 거의 모든 자산에 대한 선순위 유치권으로 담보되며, 합병, 자산 매각, 부채, 투자 및 유치권에 관한 통상적인 부정적 약정이 포함되어 있습니다.

분기별 필수 원금 상환은 유로 대출은 2025년 9월, 미화 대출은 2026년 9월부터 시작되며, 만기 시 최종 일시 상환이 예정되어 있습니다. 자산 매각, 사고 발생 또는 추가 부채에 따른 조기 상환은 의무 사항이며, 자발적 상환 및 약정 축소는 프리미엄 없이 허용됩니다.

기존 시설의 미상환 대출 잔액은 2025년 3월 28일 기준 3억 9,240만 달러였습니다. 새 구조는 유동성 여력을 강화하고 만기를 연장하며 금리 선택권을 제공하지만, 부채 담보와 레버리지 한도 유지가 필요하므로 투자자들이 주의 깊게 모니터링해야 합니다.

Novanta Inc. (NASDAQ : NOVT) a conclu un Quatrième Accord de Crédit Modifié et Reformulé le 27 juin 2025, remplaçant sa facilité de crédit de 2019 prévue à échéance en mars 2027. Le nouvel accord offre une capacité de crédit senior garantie globale d'environ 1,0 milliard de dollars US, répartie comme suit :

  • 65,31 millions d'euros, prêt à terme de 5 ans libellé en euros
  • 75 millions de dollars, prêt à terme de 5 ans en dollars US
  • 850 millions de dollars, facilité de crédit renouvelable de 5 ans

La maturité est prolongée jusqu'en juin 2030 et une option d'extension non engagée peut augmenter les engagements totaux de 350 millions de dollars supplémentaires, sous réserve de conditions habituelles. Le taux d'intérêt est fixé à (i) taux de base + 0–0,75 point(s) de pourcentage ou (ii) SOFR/SONIA/EURIBOR + 1,00–1,75 point(s) de pourcentage, avec une tarification liée au ratio d'endettement consolidé de la société. Des frais d'engagement s'appliquent à la capacité inutilisée de la facilité renouvelable.

Les principaux covenants financiers testés trimestriellement incluent : (1) un ratio d'endettement consolidé maximal de 3,5× (augmentation à 4,0× pendant quatre trimestres après des acquisitions qualifiées ≥ 50 millions de dollars) et (2) un ratio de couverture des charges fixes minimum de 1,25×. Les facilités sont garanties par des privilèges seniors sur la quasi-totalité des actifs de Novanta et de certaines filiales, et contiennent des clauses restrictives habituelles concernant les fusions, ventes d'actifs, endettement, investissements et privilèges.

L'amortissement principal trimestriel obligatoire commence en septembre 2025 pour le prêt à terme en euros et en septembre 2026 pour le prêt en dollars, avec des paiements finaux à l'échéance. Les remboursements anticipés issus de ventes d'actifs, d'événements dommageables ou d'endettement supplémentaire sont obligatoires, tandis que les remboursements volontaires et réductions d'engagement sont autorisés sans prime.

Les emprunts en cours sous l'ancienne facilité s'élevaient à 392,4 millions de dollars au 28 mars 2025. La nouvelle structure améliore la liquidité disponible, prolonge la durée et offre des options de taux d'intérêt, mais sécurise également la dette et maintient des limites d'endettement que les investisseurs doivent surveiller.

Novanta Inc. (NASDAQ: NOVT) hat am 27. Juni 2025 eine vierte geänderte und neu gefasste Kreditvereinbarung abgeschlossen, die ihre 2019er Kreditfazilität ersetzt, die ursprünglich im März 2027 fällig war. Die neue Vereinbarung sieht eine gesamte besicherte Senior-Kreditlinie von etwa 1,0 Milliarden US-Dollar vor, aufgeteilt in:

  • 65,31 Millionen Euro 5-jähriger Euro-Terminkredit
  • 75 Millionen US-Dollar 5-jähriger US-Dollar-Terminkredit
  • 850 Millionen US-Dollar 5-jährige revolvierende Kreditfazilität

Die Laufzeit wurde bis Juni 2030 verlängert, und eine nicht verpflichtende Erweiterungsoption kann die Gesamtverpflichtungen um weitere 350 Millionen US-Dollar erhöhen, vorbehaltlich üblicher Bedingungen. Die Zinsen betragen (i) Basiszinssatz + 0–0,75 Prozentpunkte oder (ii) SOFR/SONIA/EURIBOR + 1,00–1,75 Prozentpunkte, wobei die Preisgestaltung an das konsolidierte Verschuldungsverhältnis des Unternehmens gekoppelt ist. Eine Verpflichtungsgebühr wird auf ungenutzte Revolving-Kapazitäten erhoben.

Wesentliche finanzielle Auflagen, die vierteljährlich geprüft werden, umfassen: (1) ein maximales konsolidiertes Verschuldungsverhältnis von 3,5× (Anhebung auf 4,0× für vier Quartale nach qualifizierenden Akquisitionen ≥ 50 Millionen US-Dollar) und (2) ein Mindest-Festkosten-Coverage-Verhältnis von 1,25×. Die Fazilitäten sind durch vorrangige Sicherheiten auf nahezu alle Vermögenswerte von Novanta und bestimmten Tochtergesellschaften besichert und enthalten übliche negative Verpflichtungen hinsichtlich Fusionen, Vermögensverkäufen, Verschuldung, Investitionen und Sicherheiten.

Die erforderliche vierteljährliche Kapitaltilgung beginnt im September 2025 für den Euro-Terminkredit und im September 2026 für den US-Dollar-Terminkredit, mit abschließenden Ballonzahlungen bei Fälligkeit. Vorzeitige Rückzahlungen aus Vermögensverkäufen, Schadensereignissen oder zusätzlicher Verschuldung sind verpflichtend, während freiwillige Rückzahlungen und Reduzierungen der Kreditlinien ohne Prämie zulässig sind.

Die ausstehenden Darlehen unter der vorherigen Fazilität beliefen sich am 28. März 2025 auf 392,4 Millionen US-Dollar. Die neue Struktur verbessert die Liquiditätsreserven, verlängert die Laufzeit und bietet Zinsoptionen, sichert aber auch die Schulden ab und hält Verschuldungsgrenzen ein, die Investoren beobachten sollten.

Positive
  • Extended maturity from March 2027 to June 2030, reducing refinancing risk.
  • Increased total committed capacity to approximately US$1.0 billion plus US$350 million accordion, enhancing liquidity and strategic flexibility.
  • Leverage-linked pricing allows potential interest savings if leverage remains low.
  • Customary but manageable covenants (3.5× max leverage, 1.25× FCCR) preserve operating headroom.
Negative
  • Debt remains secured by substantially all assets, increasing encumbrance and priority ahead of equity.
  • Potential leverage step-up to 4.0× after sizeable acquisitions could heighten financial risk.
  • Commitment fee on unused revolver adds carrying cost even when undrawn.

Insights

TL;DR: Novanta upsizes and extends credit lines to 2030, boosting liquidity by ~US$600 m while retaining moderate leverage covenants—credit-positive.

The replacement of the 2019 facility with a US$1 billion package materially lengthens debt tenor (3-year extension) and almost triples available revolver capacity, improving short-term liquidity and funding flexibility for M&A or capex. Pricing—up to SOFR + 1.75 ppt—sits within typical BB-level spreads and is leverage-linked, incentivising deleveraging. Financial maintenance covenants set at 3.5× (4.0× post-deal) provide cushion versus the Q1-25 leverage of ~2× (not disclosed here but historical range). Security on assets adds lender protection but limits asset-based flexibility. Overall, the transaction is credit-positive due to extended maturity, accordion option, and unchanged covenant headroom.

TL;DR: Facility grants US$1 bn fire-power to 2030; beneficial for growth strategy but increases secured claims ahead of shareholders.

From an equityholder viewpoint, the enlarged revolver and accordion create capacity for bolt-on acquisitions—core to Novanta’s growth model—and remove near-term refinancing risk. Interest cost looks manageable, and voluntary prepayment flexibility offers room to de-lever if cash generation permits. However, granting senior liens subordinates existing unsecured creditors and could slightly elevate financial risk if the company draws heavily. The leverage step-up to 4× after large deals signals willingness to lever for M&A. Net effect is moderately positive given liquidity benefits outweigh the incremental secured layer.

Novanta Inc. (NASDAQ: NOVT) ha stipulato un Quarto Accordo di Credito Modificato e Rifirmato il 27 giugno 2025, che sostituisce la sua linea di credito del 2019 prevista in scadenza a marzo 2027. Il nuovo accordo prevede una capacità di credito senior garantito complessiva di circa 1,0 miliardi di dollari USA, suddivisa in:

  • 65,31 milioni di euro, prestito a termine quinquennale denominato in euro
  • 75 milioni di dollari, prestito a termine quinquennale denominato in dollari USA
  • 850 milioni di dollari, linea di credito revolving quinquennale

La scadenza è stata estesa a giugno 2030 e una clausola di estensione non vincolante può aumentare gli impegni totali di ulteriori 350 milioni di dollari, soggetti a condizioni consuete. Il tasso d’interesse è fissato a (i) Base Rate + 0–0,75 punti percentuali oppure (ii) SOFR/SONIA/EURIBOR + 1,00–1,75 punti percentuali, con il prezzo legato al rapporto di leva finanziaria consolidato della società. È prevista una commissione di impegno sulla capacità inutilizzata della linea revolving.

I principali covenant finanziari, verificati trimestralmente, includono: (1) un rapporto massimo di leva finanziaria consolidata di 3,5× (con aumento a 4,0× per quattro trimestri dopo acquisizioni qualificate ≥ 50 milioni di dollari) e (2) un rapporto minimo di copertura delle spese fisse di 1,25×. Le linee di credito sono garantite da privilegi senior su quasi tutti gli asset di Novanta e di alcune sue controllate e includono clausole negative standard riguardanti fusioni, vendite di asset, indebitamento, investimenti e privilegi.

L’ammortamento del capitale richiesto trimestralmente inizia a settembre 2025 per il prestito a termine in euro e a settembre 2026 per quello in dollari, con pagamenti finali a scadenza. I rimborsi anticipati derivanti da vendite di asset, eventi di danno o debito incrementale sono obbligatori, mentre quelli volontari e le riduzioni di impegno sono consentiti senza penali.

Le esposizioni in essere sotto la precedente linea erano di 392,4 milioni di dollari al 28 marzo 2025. La nuova struttura migliora la liquidità disponibile, estende la durata e offre opzioni sui tassi di interesse, ma garantisce anche il debito e mantiene limiti di leva finanziaria che gli investitori devono monitorare.

Novanta Inc. (NASDAQ: NOVT) firmó un Cuarto Acuerdo de Crédito Modificado y Restablecido el 27 de junio de 2025, que reemplaza su línea de crédito de 2019 programada para vencer en marzo de 2027. El nuevo acuerdo ofrece una capacidad de crédito senior garantizado total de aproximadamente 1.000 millones de dólares estadounidenses, desglosada en:

  • 65,31 millones de euros, préstamo a plazo a 5 años denominado en euros
  • 75 millones de dólares, préstamo a plazo a 5 años en dólares estadounidenses
  • 850 millones de dólares, línea de crédito revolvente a 5 años

La vencimiento se extiende hasta junio de 2030, y una característica de extensión no comprometida puede aumentar los compromisos totales en otros 350 millones de dólares, sujeto a condiciones habituales. El interés se establece en (i) Tasa Base + 0–0,75 puntos porcentuales o (ii) SOFR/SONIA/EURIBOR + 1,00–1,75 puntos porcentuales, con la tarifa ligada al ratio de apalancamiento consolidado de la empresa. Se aplica una comisión por compromiso sobre la capacidad no utilizada del revolvente.

Los principales covenants financieros evaluados trimestralmente incluyen: (1) ratio máximo de apalancamiento consolidado de 3,5× (aumento a 4,0× durante cuatro trimestres tras adquisiciones calificadas ≥ 50 millones de dólares) y (2) ratio mínimo de cobertura de gastos fijos de 1,25×. Las facilidades están garantizadas por gravámenes senior sobre prácticamente todos los activos de Novanta y ciertas subsidiarias, e incluyen cláusulas negativas habituales sobre fusiones, ventas de activos, endeudamiento, inversiones y gravámenes.

La amortización principal requerida trimestralmente comienza en septiembre de 2025 para el préstamo a plazo en euros y en septiembre de 2026 para el préstamo en dólares, con pagos finales al vencimiento. Los prepagos derivados de ventas de activos, eventos de siniestro o deuda incremental son obligatorios, mientras que los prepagos voluntarios y las reducciones de compromiso están permitidos sin penalización.

Los préstamos pendientes bajo la línea anterior eran de 392,4 millones de dólares al 28 de marzo de 2025. La nueva estructura mejora la liquidez disponible, extiende el plazo y ofrece opciones sobre tasas de interés, pero también garantiza la deuda y mantiene límites de apalancamiento que los inversores deben vigilar.

Novanta Inc. (NASDAQ: NOVT)는 2025년 6월 27일에 2019년 시설을 대체하는 4차 수정 및 재작성 신용 계약을 체결했습니다. 기존 시설은 2027년 3월 만기가 예정되어 있었습니다. 새 계약은 총 약 10억 달러의 선순위 담보 신용 한도를 제공하며, 세부 내역은 다음과 같습니다:

  • 6,531만 유로 5년 만기 유로화 대출
  • 7,500만 달러 5년 만기 미화 대출
  • 8억 5천만 달러 5년 만기 리볼빙 신용 한도

만기는 2030년 6월까지 연장되었으며, 비확약 확장 옵션을 통해 총 약정액을 추가로 3억 5천만 달러까지 늘릴 수 있습니다(통상 조건 충족 시). 이자는 (i) 기준금리 + 0~0.75%포인트 또는 (ii) SOFR/SONIA/EURIBOR + 1.00~1.75%포인트로 설정되며, 회사의 통합 레버리지 비율에 따라 금리가 조정됩니다. 미사용 리볼빙 한도에 대해 약정 수수료가 부과됩니다.

주요 재무 약정은 분기별로 검토되며, (1) 최대 통합 레버리지 비율 3.5배(50백만 달러 이상 적격 인수 후 4분기 동안 4.0배로 상향 조정) 및 (2) 최소 고정비용 커버리지 비율 1.25배를 포함합니다. 이 시설들은 Novanta 및 일부 자회사의 거의 모든 자산에 대한 선순위 유치권으로 담보되며, 합병, 자산 매각, 부채, 투자 및 유치권에 관한 통상적인 부정적 약정이 포함되어 있습니다.

분기별 필수 원금 상환은 유로 대출은 2025년 9월, 미화 대출은 2026년 9월부터 시작되며, 만기 시 최종 일시 상환이 예정되어 있습니다. 자산 매각, 사고 발생 또는 추가 부채에 따른 조기 상환은 의무 사항이며, 자발적 상환 및 약정 축소는 프리미엄 없이 허용됩니다.

기존 시설의 미상환 대출 잔액은 2025년 3월 28일 기준 3억 9,240만 달러였습니다. 새 구조는 유동성 여력을 강화하고 만기를 연장하며 금리 선택권을 제공하지만, 부채 담보와 레버리지 한도 유지가 필요하므로 투자자들이 주의 깊게 모니터링해야 합니다.

Novanta Inc. (NASDAQ : NOVT) a conclu un Quatrième Accord de Crédit Modifié et Reformulé le 27 juin 2025, remplaçant sa facilité de crédit de 2019 prévue à échéance en mars 2027. Le nouvel accord offre une capacité de crédit senior garantie globale d'environ 1,0 milliard de dollars US, répartie comme suit :

  • 65,31 millions d'euros, prêt à terme de 5 ans libellé en euros
  • 75 millions de dollars, prêt à terme de 5 ans en dollars US
  • 850 millions de dollars, facilité de crédit renouvelable de 5 ans

La maturité est prolongée jusqu'en juin 2030 et une option d'extension non engagée peut augmenter les engagements totaux de 350 millions de dollars supplémentaires, sous réserve de conditions habituelles. Le taux d'intérêt est fixé à (i) taux de base + 0–0,75 point(s) de pourcentage ou (ii) SOFR/SONIA/EURIBOR + 1,00–1,75 point(s) de pourcentage, avec une tarification liée au ratio d'endettement consolidé de la société. Des frais d'engagement s'appliquent à la capacité inutilisée de la facilité renouvelable.

Les principaux covenants financiers testés trimestriellement incluent : (1) un ratio d'endettement consolidé maximal de 3,5× (augmentation à 4,0× pendant quatre trimestres après des acquisitions qualifiées ≥ 50 millions de dollars) et (2) un ratio de couverture des charges fixes minimum de 1,25×. Les facilités sont garanties par des privilèges seniors sur la quasi-totalité des actifs de Novanta et de certaines filiales, et contiennent des clauses restrictives habituelles concernant les fusions, ventes d'actifs, endettement, investissements et privilèges.

L'amortissement principal trimestriel obligatoire commence en septembre 2025 pour le prêt à terme en euros et en septembre 2026 pour le prêt en dollars, avec des paiements finaux à l'échéance. Les remboursements anticipés issus de ventes d'actifs, d'événements dommageables ou d'endettement supplémentaire sont obligatoires, tandis que les remboursements volontaires et réductions d'engagement sont autorisés sans prime.

Les emprunts en cours sous l'ancienne facilité s'élevaient à 392,4 millions de dollars au 28 mars 2025. La nouvelle structure améliore la liquidité disponible, prolonge la durée et offre des options de taux d'intérêt, mais sécurise également la dette et maintient des limites d'endettement que les investisseurs doivent surveiller.

Novanta Inc. (NASDAQ: NOVT) hat am 27. Juni 2025 eine vierte geänderte und neu gefasste Kreditvereinbarung abgeschlossen, die ihre 2019er Kreditfazilität ersetzt, die ursprünglich im März 2027 fällig war. Die neue Vereinbarung sieht eine gesamte besicherte Senior-Kreditlinie von etwa 1,0 Milliarden US-Dollar vor, aufgeteilt in:

  • 65,31 Millionen Euro 5-jähriger Euro-Terminkredit
  • 75 Millionen US-Dollar 5-jähriger US-Dollar-Terminkredit
  • 850 Millionen US-Dollar 5-jährige revolvierende Kreditfazilität

Die Laufzeit wurde bis Juni 2030 verlängert, und eine nicht verpflichtende Erweiterungsoption kann die Gesamtverpflichtungen um weitere 350 Millionen US-Dollar erhöhen, vorbehaltlich üblicher Bedingungen. Die Zinsen betragen (i) Basiszinssatz + 0–0,75 Prozentpunkte oder (ii) SOFR/SONIA/EURIBOR + 1,00–1,75 Prozentpunkte, wobei die Preisgestaltung an das konsolidierte Verschuldungsverhältnis des Unternehmens gekoppelt ist. Eine Verpflichtungsgebühr wird auf ungenutzte Revolving-Kapazitäten erhoben.

Wesentliche finanzielle Auflagen, die vierteljährlich geprüft werden, umfassen: (1) ein maximales konsolidiertes Verschuldungsverhältnis von 3,5× (Anhebung auf 4,0× für vier Quartale nach qualifizierenden Akquisitionen ≥ 50 Millionen US-Dollar) und (2) ein Mindest-Festkosten-Coverage-Verhältnis von 1,25×. Die Fazilitäten sind durch vorrangige Sicherheiten auf nahezu alle Vermögenswerte von Novanta und bestimmten Tochtergesellschaften besichert und enthalten übliche negative Verpflichtungen hinsichtlich Fusionen, Vermögensverkäufen, Verschuldung, Investitionen und Sicherheiten.

Die erforderliche vierteljährliche Kapitaltilgung beginnt im September 2025 für den Euro-Terminkredit und im September 2026 für den US-Dollar-Terminkredit, mit abschließenden Ballonzahlungen bei Fälligkeit. Vorzeitige Rückzahlungen aus Vermögensverkäufen, Schadensereignissen oder zusätzlicher Verschuldung sind verpflichtend, während freiwillige Rückzahlungen und Reduzierungen der Kreditlinien ohne Prämie zulässig sind.

Die ausstehenden Darlehen unter der vorherigen Fazilität beliefen sich am 28. März 2025 auf 392,4 Millionen US-Dollar. Die neue Struktur verbessert die Liquiditätsreserven, verlängert die Laufzeit und bietet Zinsoptionen, sichert aber auch die Schulden ab und hält Verschuldungsgrenzen ein, die Investoren beobachten sollten.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Manko Joseph M. Jr.

(Last) (First) (Middle)
1717 ARCH STREET
37TH FLOOR

(Street)
PHILADELPHIA PA 19103

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
KORU Medical Systems, Inc. [ KRMD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/30/2025 A 4,189 A $0(1) 5,867,419 I By Horton Capital Partners Fund, LP(2)
Common Stock 517,200 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
1. Name and Address of Reporting Person*
Manko Joseph M. Jr.

(Last) (First) (Middle)
1717 ARCH STREET
37TH FLOOR

(Street)
PHILADELPHIA PA 19103

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
X Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Horton Capital Management, LLC

(Last) (First) (Middle)
1717 ARCH STREET
37TH FLOOR

(Street)
PHILADELPHIA PA 19103

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Horton Capital Partners, LLC

(Last) (First) (Middle)
1717 ARCH STREET
37TH FLOOR

(Street)
PHILADELPHIA PA 19103

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Horton Capital Partners Fund, L.P.

(Last) (First) (Middle)
1717 ARCH STREET
37TH FLOOR

(Street)
PHILADELPHIA PA 19103

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
Explanation of Responses:
1. See Exhibit 99.1 to this Form 4 for explanation of note (1).
2. See Exhibit 99.1 to this Form 4 for explanation of note (2).
Remarks:
The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person.
/s/ Joseph M. Manko, Jr. 07/02/2025
/s/ Joseph M. Manko, Jr., Managing Member of Horton Capital Management, LLC 07/02/2025
/s/ Joseph M. Manko, Jr., Managing Member of Horton Capital Partners, LLC 07/02/2025
/s/ Joseph M. Manko, Jr., Managing Member of Horton Capital Partners, LLC, the General Partner of Horton Capital Partners Fund, LP 07/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How large is Novanta's new credit facility announced in the June 27 2025 8-K?

The agreement provides roughly US$1.0 billion in committed capacity: €65.31 m term loan, $75 m term loan and an $850 m revolver.

When do the new senior credit facilities mature?

All tranches mature on 27 June 2030, extending the prior 2027 maturity by three years.

What are the key financial covenants under Novanta's new agreement?

Quarterly tests require a maximum consolidated leverage ratio of 3.5× (4.0× post-acquisition) and a minimum fixed-charge coverage ratio of 1.25×.

What interest rates apply to borrowings under the facility?

Loans bear Base Rate + 0–0.75 % or SOFR/SONIA/EURIBOR + 1.00–1.75 %, depending on the company's leverage tier.

Does the agreement allow Novanta to increase borrowings further?

Yes. An uncommitted accordion feature permits up to an additional $350 million in aggregate commitments, subject to conditions.
Koru Med Sys

NASDAQ:KRMD

KRMD Rankings

KRMD Latest News

KRMD Latest SEC Filings

KRMD Stock Data

165.18M
42.63M
7.12%
50.93%
1.11%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
MAHWAH